Navigation Links
Baxter Declares Quarterly Dividend
Date:7/29/2008

DEERFIELD, Ill., July 29 /PRNewswire-FirstCall/ -- The Board of Directors of Baxter International Inc. (NYSE: BAX) today declared a quarterly dividend of $0.2175 per share of Baxter common stock.

This payment represents a continuation of the current rate, which was increased earlier this year by 30 percent. This quarterly dividend is payable on October 1, 2008 to shareholders of record as of September 10, 2008.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.


'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
2. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
3. Baxters Board of Directors Declares Quarterly Dividend
4. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
5. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
6. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
7. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
8. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
9. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
10. Baxter Declares Quarterly Dividend
11. Baxter Provides Update on Heparin Reactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , March 1, 2017 Illustris Pharmaceuticals, ... to launch its revolutionary delivery technology platform.  The leadership ... of Medicis, Mark Prygocki , former President of ... S. K. Tan , founding member of Derma-Rx ... in aesthetics and cosmeceuticals in Asia ...
(Date:3/1/2017)... ... 2017 , ... At interpack 2017, held in Düsseldorf, Germany ... quality can help food and pharmaceutical manufacturers improve processes and increase competitiveness in ... to vision inspection and metal detection – will be on display, as well ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... manufacturing technology for use in filling injectable drug products into vials, syringes, and ... SA25 robotic work-cell . CEO of Singota Solutions Alisa Wright expressed the importance ...
(Date:2/28/2017)... Calif. , Feb. 28, 2017   Sienna ... and aesthetics company, is pleased to announce that ... advisor to Sienna,s CEO and Board of Directors. Dr. ... and chief executive officer of Allergan for 17 years. ... return to dermatology and aesthetics. "I look ...
Breaking Biology Technology:
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 8, 2017 About Voice Recognition Biometrics ... match it against a stored voiceprint template. Acoustic ... cadence, and tone are compared to distinguish between ... installation, as most PCs already have a microphone ... Voice recognition biometrics are most likely to be ...
Breaking Biology News(10 mins):